ESC 2015 Schedule: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (10 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
÷ | |||
Here is the page we will use to coordinate the TV events at ESC 2015. Open time slots are indicated below in red. | Here is the page we will use to coordinate the TV events at ESC 2015. Open time slots are indicated below in red. | ||
| Line 7: | Line 7: | ||
== Click on Date for Detailed Schedule == | == Click on Date for Detailed Schedule == | ||
[[{{PAGENAME}}#Sunday, August 30, 2015| Sunday, August 30, 2015]] | |||
[[{{PAGENAME}}#Monday, August 31, 2015| Monday, August 31, 2015]] | [[{{PAGENAME}}#Monday, August 31, 2015| Monday, August 31, 2015]] | ||
[[{{PAGENAME}}#Tuesday, September 1, 2015| Tuesday, September 1, 2015]] | [[{{PAGENAME}}#Tuesday, September 1, 2015| Tuesday, September 1, 2015]] | ||
[[{{PAGENAME}}#Wednesday, September 2, 2015| Wednesday, September 2, 2015]] | |||
---- | ---- | ||
== Sunday, August 30, 2015 == | |||
=== 4:30 PM === | |||
* '''Interviewee:''' Dr. Robert Byrne | |||
* '''Topic:''' ESC 2015 Wrap-Up from the Perspective of the UK/Ireland | |||
== Monday, August 31, 2015 == | == Monday, August 31, 2015 == | ||
| Line 20: | Line 29: | ||
=== 8:30 AM === | === 8:30 AM === | ||
* '''Interviewee:'''Dr. Vivek Reddy | * '''Interviewee:''' Dr. Vivek Reddy | ||
* '''Topic:'''Safety and efficacy of a Leadless pacemaker: results from the LEADLESS II clinical trial | * '''Topic:''' Safety and efficacy of a Leadless pacemaker: results from the LEADLESS II clinical trial | ||
* '''Embargo Lift:''' Sunday, August 30th at 5:38 PM | * '''Embargo Lift:''' Sunday, August 30th at 5:38 PM | ||
| Line 28: | Line 37: | ||
=== 9:30 AM === | === 9:30 AM === | ||
* '''Interviewee: '''Dr. Kazuaki Kaitani (and Dr. Atsushi Kobori) | * '''Interviewee: ''' Dr. Kazuaki Kaitani (and Dr. Atsushi Kobori) | ||
* '''Topic: '''Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) Trial '''AND '''Efficacy of adenosine triphosphate guided ablation for atrial fibrillation: UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) Trial | * '''Topic: ''' Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) Trial '''AND '''Efficacy of adenosine triphosphate guided ablation for atrial fibrillation: UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) Trial | ||
* '''Embargo Lift:''' Sunday, August 30th at 4:30 PM''' and''' Sunday, | * '''Embargo Lift:''' Sunday, August 30th at 4:30 PM''' and''' Sunday, August 30th at 4:30 PM | ||
=== 10:00 AM === | === 10:00 AM === | ||
* '''Interviewee:'''Pr. Michel Ovize | * '''Interviewee:''' Pr. Michel Ovize | ||
* '''Topic:'''Does cyclosporine improve clinical outcomes in STEMI patients? The CIRCUS trial | * '''Topic:''' Does cyclosporine improve clinical outcomes in STEMI patients? The CIRCUS trial | ||
* '''Embargo Lift: '''Sunday, August 30th, at 12:27 PM | * '''Embargo Lift: '''Sunday, August 30th, at 12:27 PM | ||
=== 10:30 | === 10:30 AM === | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
=== 11:30 AM | === 11:30 AM === | ||
* '''Interviewee:'''Dr. Morris Brown | * '''Interviewee:''' Dr. Morris Brown | ||
* '''Topic: | * '''Topic:''' Principal results from Prevention And Treatment of Hypertension With Algorithm based therapY (PATHWAY): comparison of single and combination diuretics in essential hypertension - PATHWAY-3 | ||
* '''Embargo Lift:'''Monday August 31st at 5:16 PM | * '''Embargo Lift:''' Monday August 31st at 5:16 PM | ||
=== 12:00 PM === | === 12:00 PM === | ||
* '''Interviewee:''' Dr. Luigi Di Biase | |||
* '''Topic:''' Effect of empirical left atrial appendage isolation on long-term procedure outcome in patients with long-standing persistent atrial fibrillation undergoing catheter ablation: results from the BELIEF | |||
* '''Embargo Lift:''' Sunday, August 30th at 4:53 PM | |||
=== 12:30 PM === | === 12:30 PM === | ||
| Line 60: | Line 66: | ||
=== 1:30 PM === | === 1:30 PM === | ||
* '''Interviewee:''' Dr. Eldrin Lewis | |||
* '''Topic:''' The evaluation of Lixisenatide in acute coronary syndromes (ELIXA). | |||
* '''Embargo Lift:''' Monday, August 31st at 11:36 AM | |||
=== 2:00 PM === | === 2:00 PM === | ||
| Line 71: | Line 79: | ||
=== 3:00 PM === | === 3:00 PM === | ||
* '''Interviewee:'''Dr. Basil Lewis | * '''Interviewee:''' Dr. Basil Lewis | ||
* '''Topic: '''ESC 2015 Wrap-up in Hebrew | * '''Topic: '''ESC 2015 Wrap-up in Hebrew | ||
=== 3:30 PM === | === 3:30 PM === | ||
* '''Interviewee:'''Dr. Renato Lopes | * '''Interviewee:''' Dr. Renato Lopes | ||
* '''Topic:''' ESC 2015 Wrap-up in Portuguese | * '''Topic:''' ESC 2015 Wrap-up in Portuguese | ||
=== 4:00 PM === | === 4:00 PM === | ||
* '''Interviewee:'''Pr. Freek Verheugt | * '''Interviewee:''' Pr. Freek Verheugt | ||
* '''Topic: '''ESC 2015 Wrap-up from the Perspective of the Netherlands | * '''Topic: '''ESC 2015 Wrap-up from the Perspective of the Netherlands | ||
| Line 117: | Line 125: | ||
=== 11:30 AM === | === 11:30 AM === | ||
* '''Interviewee:''' Dr. Marco Valgimigli | |||
* '''Topic: '''Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX (MATRIX Antithrombin) | |||
* '''Embargo Lift:''' Tuesday, September 1st at 5:24 PM | |||
=== 12:00 PM === | === 12:00 PM === | ||
* '''Interviewee:''' Pr. Thomas MacDonald | |||
* '''Topic: '''The Standard care versus Celecoxib Outcome Trial (SCOT); a randomised, trial comparing the cardiovascular safety of celecoxib versus traditional non-steroidal anti-inflammatory drugs. | |||
* '''Embargo Lift:''' Monday, August 31st at 11:54 AM | |||
=== 12:30 PM === | === 12:30 PM === | ||
| Line 136: | Line 148: | ||
=== 2:00 PM === | === 2:00 PM === | ||
* '''Interviewee: ''' Dr. Frank Rademakers | |||
* '''Topic: '''Determining Optimal non-invasive Parameters for the Prediction of Left vEntricular morphologic and functional Remodeling in Chronic Ischemic Patients | |||
* '''Embrago Lift: '''Sunday, August 30th at 11:18 AM | |||
=== 3:00 PM === | |||
* '''Interviewee: '''Dr. Gerasimos Filippatos | * '''Interviewee: '''Dr. Gerasimos Filippatos | ||
* '''Topic:''' Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial | * '''Topic:''' Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial | ||
* '''Embargo Lift:''' Monday, August 31st at 11:18 AM | * '''Embargo Lift:''' Monday, August 31st at 11:18 AM | ||
=== 3:30 PM === | |||
=== 3:30 PM | |||
* '''Interviewee:''' Dr. Carlos A. Morillo | * '''Interviewee:''' Dr. Carlos A. Morillo | ||
* '''Topic: '''The BENznidazole Evaluation For Interrupting Trypanosomiasis trial | * '''Topic: '''The BENznidazole Evaluation For Interrupting Trypanosomiasis trial | ||
| Line 152: | Line 163: | ||
=== 4:00 PM === | === 4:00 PM === | ||
* '''Interviewee: ''' | * '''Interviewee: '''Dr. Stefan James (and guest Dr. Jonas Oldgren) | ||
* '''Topic: '''Wrap-up from a Scandinavian Perspective | * '''Topic: '''Wrap-up from a Scandinavian Perspective | ||
=== 4:30 PM | === 4:30 PM === | ||
* '''Interviewee:''' Dr. | * '''Interviewee: ''' Dr. Sergio Leonardi (and guest Pr. Gaetano De Ferrari) | ||
* '''Topic:''' | * '''Topic: '''ESC 2015 Wrap-Up in Italian | ||
=== 5:00 PM - 6:00 PM === | === 5:00 PM - 6:00 PM === | ||
| Line 164: | Line 174: | ||
* Topic: Early aldosterone blockade in acute myocardial infarction: the randomized ALBATROSS Trial '''AND''' Assessment of an education and guidance program for apixaban adherence in non-valvular atrial fibrillation: the randomized AEGEAN study '''AND''' ESC 2015 Wrap-up in''' '''French | * Topic: Early aldosterone blockade in acute myocardial infarction: the randomized ALBATROSS Trial '''AND''' Assessment of an education and guidance program for apixaban adherence in non-valvular atrial fibrillation: the randomized AEGEAN study '''AND''' ESC 2015 Wrap-up in''' '''French | ||
* Embargo Lift: Sunday, August 30th at 11:36 AM (ALBATROSS) '''and '''Sunday, August 30th at 5:16 PM (AEGEAN) | * Embargo Lift: Sunday, August 30th at 11:36 AM (ALBATROSS) '''and '''Sunday, August 30th at 5:16 PM (AEGEAN) | ||
== Wednesday, September 2, 2015 == | |||
=== 8:00 AM === | |||
<font color=red>OPEN TIME SLOT</font> | |||
=== 8:30 AM === | |||
<font color=red>OPEN TIME SLOT</font> | |||
=== 9:00 AM === | |||
* '''Interviewee: ''' Pr. Harvey White | |||
* '''Topic: ''' ESC 2015 Wrap-Up from Perspective from the Pacific Rim | |||
=== 9:30 AM === | |||
* '''Interviewee: ''' Pr. Sigmund Silber | |||
* '''Topic: ''' ESC 2015 Wrap-Up in German | |||
Latest revision as of 14:42, 12 August 2015
÷ Here is the page we will use to coordinate the TV events at ESC 2015. Open time slots are indicated below in red.
Filming Location: Crowne Plaza London - Dockland, Western Gateway, Royal Victoria Dock, London, E16 1AL, United Kingdom
Click on Date for Detailed Schedule
Sunday, August 30, 2015
4:30 PM
- Interviewee: Dr. Robert Byrne
- Topic: ESC 2015 Wrap-Up from the Perspective of the UK/Ireland
Monday, August 31, 2015
8:00 AM
OPEN TIME SLOT
8:30 AM
- Interviewee: Dr. Vivek Reddy
- Topic: Safety and efficacy of a Leadless pacemaker: results from the LEADLESS II clinical trial
- Embargo Lift: Sunday, August 30th at 5:38 PM
9:00 AM
OPEN TIME SLOT
9:30 AM
- Interviewee: Dr. Kazuaki Kaitani (and Dr. Atsushi Kobori)
- Topic: Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) Trial AND Efficacy of adenosine triphosphate guided ablation for atrial fibrillation: UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) Trial
- Embargo Lift: Sunday, August 30th at 4:30 PM and Sunday, August 30th at 4:30 PM
10:00 AM
- Interviewee: Pr. Michel Ovize
- Topic: Does cyclosporine improve clinical outcomes in STEMI patients? The CIRCUS trial
- Embargo Lift: Sunday, August 30th, at 12:27 PM
10:30 AM
OPEN TIME SLOT
11:30 AM
- Interviewee: Dr. Morris Brown
- Topic: Principal results from Prevention And Treatment of Hypertension With Algorithm based therapY (PATHWAY): comparison of single and combination diuretics in essential hypertension - PATHWAY-3
- Embargo Lift: Monday August 31st at 5:16 PM
12:00 PM
- Interviewee: Dr. Luigi Di Biase
- Topic: Effect of empirical left atrial appendage isolation on long-term procedure outcome in patients with long-standing persistent atrial fibrillation undergoing catheter ablation: results from the BELIEF
- Embargo Lift: Sunday, August 30th at 4:53 PM
12:30 PM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
- Interviewee: Dr. Eldrin Lewis
- Topic: The evaluation of Lixisenatide in acute coronary syndromes (ELIXA).
- Embargo Lift: Monday, August 31st at 11:36 AM
2:00 PM
OPEN TIME SLOT
2:30 PM
- Interviewee: Dr. Dirk Westermann
- Topic: Accurate and rapid diagnosis of myocardial infarction using a high sensitivity Troponin I 1-hour algorithm
- Embargo Lift: Sunday, August 30th at 11:00 AM
3:00 PM
- Interviewee: Dr. Basil Lewis
- Topic: ESC 2015 Wrap-up in Hebrew
3:30 PM
- Interviewee: Dr. Renato Lopes
- Topic: ESC 2015 Wrap-up in Portuguese
4:00 PM
- Interviewee: Pr. Freek Verheugt
- Topic: ESC 2015 Wrap-up from the Perspective of the Netherlands
4:30 PM
OPEN TIME SLOT
Tuesday, September 1, 2015
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
- Interviewee: Dr. Takeshi Kimura
- Topic: ABSORB Japan: 12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent
- Embrago Lift: Tuesday, September 1st at 5:06 PM
10:00 AM
- Interviewee: Dr. Gérard Helft
- Topic: The OPTIDUAL trial: 12 vs 48 months of clopidogrel after drug-eluting stent placement
- Embargo Lift: Monday, August 31st at 12:12 PM
10:30 AM
- Interviewee: Dr. Pamela Douglas
- Topic: Outcomes of an FFRCT diagnostic strategy versus usual care in suspected coronary artery disease: results from the PLATFORM (Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts) study
- Embargo Lift: Tuesday, September 1st at 4:30 PM
11:00 AM
- Interviewee: Dr. Hisao Ogawa
- Topic: A trial of Telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD) : the large biomarkers study with 1228 patients AND ESC 2015 Wrap-up in Japanese
- Embargo Lift: Monday August 31st at 4:30 PM
11:30 AM
- Interviewee: Dr. Marco Valgimigli
- Topic: Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX (MATRIX Antithrombin)
- Embargo Lift: Tuesday, September 1st at 5:24 PM
12:00 PM
- Interviewee: Pr. Thomas MacDonald
- Topic: The Standard care versus Celecoxib Outcome Trial (SCOT); a randomised, trial comparing the cardiovascular safety of celecoxib versus traditional non-steroidal anti-inflammatory drugs.
- Embargo Lift: Monday, August 31st at 11:54 AM
12:30 PM
OPEN TIME SLOT
1:00 PM
- Interviewee: Dr. Gregg Stone
- Topic: Peri-infarct zone pacing to prevent adverse left ventricular remodeling in patients with very large myocardial infarction
- Embargo Lift: Sunday, August 30th at 11:54 AM
1:30 PM
- Interviewee: Dr. Patrick Serruys
- Topic: Everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents in patients with acute myocardial infarction. Results of the ABSORB STEMI TROFI II trial.
- Embargo Lift: Tuesday, September 1st at 4:48 PM
2:00 PM
- Interviewee: Dr. Frank Rademakers
- Topic: Determining Optimal non-invasive Parameters for the Prediction of Left vEntricular morphologic and functional Remodeling in Chronic Ischemic Patients
- Embrago Lift: Sunday, August 30th at 11:18 AM
3:00 PM
- Interviewee: Dr. Gerasimos Filippatos
- Topic: Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial
- Embargo Lift: Monday, August 31st at 11:18 AM
3:30 PM
- Interviewee: Dr. Carlos A. Morillo
- Topic: The BENznidazole Evaluation For Interrupting Trypanosomiasis trial
- Embargo Lift: Tuesday, September 1st at 12:08 PM
4:00 PM
- Interviewee: Dr. Stefan James (and guest Dr. Jonas Oldgren)
- Topic: Wrap-up from a Scandinavian Perspective
4:30 PM
- Interviewee: Dr. Sergio Leonardi (and guest Pr. Gaetano De Ferrari)
- Topic: ESC 2015 Wrap-Up in Italian
5:00 PM - 6:00 PM
- Interviewee: Pr. Gilles Montalescot
- Topic: Early aldosterone blockade in acute myocardial infarction: the randomized ALBATROSS Trial AND Assessment of an education and guidance program for apixaban adherence in non-valvular atrial fibrillation: the randomized AEGEAN study AND ESC 2015 Wrap-up in French
- Embargo Lift: Sunday, August 30th at 11:36 AM (ALBATROSS) and Sunday, August 30th at 5:16 PM (AEGEAN)
Wednesday, September 2, 2015
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
- Interviewee: Pr. Harvey White
- Topic: ESC 2015 Wrap-Up from Perspective from the Pacific Rim
9:30 AM
- Interviewee: Pr. Sigmund Silber
- Topic: ESC 2015 Wrap-Up in German